Back to results
US 2016/0109452 A1Published application
Lung cancer biomarker
AssigneesAcademia Sinica, National Taiwan University
InventorsSHUI-TEIN CHEN, CHONG-JEN YU, POTPROMMANEE LADDAWAN, HAOU-TZONG MA
Life of this patent
Estimating the term…
Abstract
The present invention relates to a lung cancer biomarker for diagnosing early stage lung cancers or predicting prognosis of lung cancers, which comprises a GM2AP protein. The present invention also relates to a method for diagnosing early stage lung cancers or predicting prognosis of lung cancers in vitro by detection of the biomarker.
Claims20
A lung cancer biomarker for diagnosing early stage lung cancers or predicting prognosis of lung cancers, comprising a GM2AP protein (SEQ ID No:
- 1 or SEQ ID No:
- 2).
Dependencies are inferred from the claim text.